studies of antigen presentation of peptides by MHC class I molecules
studies of antigen presentation of peptides by MHC class I molecules
批准号:
05454204
负责人:
TAKIGUCHI Masafumi
金额:
$4.35万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994
中文摘要
1.我们发现HLA-B35分子的组装速度比HLA-B51分子快。可以推测,肽与这些HLA I类分子的结合亲和力的差异导致组装速率的差异。为了研究肽与HLA I类分子的结合,我们使用转染HLA I类基因的RMA-S细胞建立了新的结合试验。分析携带HLA-B35或B51的锚残基的肽与这些HLA I类分子的结合表明,肽与HLA-B51的结合亲和力明显弱于与HLA-B35的结合亲和力。这些结果表明,这些肽在内质网中的组装速率的差异可能是由于肽与这些HLA I类分子结合的差异造成的。2.为了阐明T细胞识别的自身肽,我们尝试分离HLA-B51同种异体反应性CTL识别的同种异体肽。检测到一个HLA-B51同种异体反应性CTL克隆识别的TAP依赖性肽。该方法对抗原提呈和T细胞增殖的研究具有重要意义。3.利用人次要组织相容性抗原(hmH)特异性CTL克隆研究了hmH抗原的多态性和抗原提呈。CTL克隆杀伤大多数表达HLA-B35的靶细胞,而它们不能杀伤表达HLA-B35亚型的细胞。由于特异性hmH肽可以从表达HLA-B35亚型的这些细胞中分离,因此认为hmH抗原在群体中是保守的。
英文摘要
1.We found that assembly rate of HLA-B35 molecules is faster than that of HLA-B51 molecules. One can speculate that the difference of peptide binding affinity to these HLA class I molecules result in that of assembly rate. To investigate peptide binding to HLA class I molecules, we established novel binding assay using RMA-S cells trasnfected with HLA class I genes. Analysis of binding of peptides carrying anchor residues of HLA-B35 or B51 to these HLA class I molecules indicate that the peptide binding affinity to HLA-B51 is significantly weaker than that to HLA-B35. These findings imply that the difference of assembly rate may result from that of peptide binding to these HLA class I molecules in endoplasmic reticurum.2.In order to clarify self-peptides recognized by T cells, we attempted to isolate allopeptides recognized by HLA-B51 alloreactive CTL.In HPLC fraction of peptides isolated from purified HLA-B51 molecules, a TAP dependent peptide recognized by one HLA-B51 alloreactive CTL clone was detected. This approach is very useful for studies of antigen presentation and T cell recognition.3.Polymorphism and antigen presentation of human minor histocompatibility (hmH) antigens were studied using hmH specific CTL clones. The CTL clones killed most target cells expressing HLA-B35, while they failed to kill the cells expressing HLA-B35 subtypes. Since the specific hmH peptides could be isolated form these cells expressing HLA-B35 subytypes, hmH antigens are thought to be conserved among populations.
期刊论文(71)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kristen Falk: "Peptide motifs of HLA-A1,-A11,-A31and-A33 molewles." Immunogenetics. 40. 238-241 (1994)
Kristen Falk:“HLA-A1、-A11、-A31 和-A33 分子的肽基序。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masafumi Takiguchi: "The role of conserved residue in pocket A and polymorphic resiclue in pocket E of HLA-B^*35 in presentation of human minor histocoupatibility peptides to T cells." International Immunology. 6. 1345-1352 (1994)
Masafumi Takiguchi:“HLA-B^*35 口袋 A 中的保守残基和口袋 E 中的多态残基在将人类次要组织偶联肽呈递给 T 细胞中的作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshifumi Beck: "Polymorphism of human minor histoumpatibility antigen:T cell recognition of humn minor histoumpabilility peptides presented by HLA-B35 subtype molewles" Jounal of Experimental Medicine. (印刷中).
Yoshifumi Beck:“人类次要组织相容性抗原的多态性:HLA-B35 亚型鼹鼠呈现的人类次要组织相容性肽的 T 细胞识别”实验医学杂志(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ann B.Hill: "Different rate of HLA class I assembly which are detemined by amino acid sequence in the alpha-2 domain." Immunogenetics.37. 95-101 (1993)
Ann B.Hill:“HLA I 类组装的不同速率由 alpha-2 结构域中的氨基酸序列决定。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshifumi Beck: "Expression of human minor histocompatibility autigen on cultured kidney cells." European Journal of Immunology. 23. 467-472 (1993)
Yoshifumi Beck:“人次要组织相容性自闭原在培养肾细胞上的表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 36 条
A study of therapy and prevention in a Vietnamese cohort of HIV-1 infection
-
批准号:15H02658
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$26.96万
-
财政年份:2015
-
负责人:TAKIGUCHI Masafumi
-
依托单位:
A study of HIV-1 escape mutants selected by cellular immunity
-
批准号:20390134
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.48万
-
财政年份:2008
-
负责人:TAKIGUCHI Masafumi
-
依托单位:
Escape mechanisms of HIV-1 from HIV-1-specific CTLs
-
批准号:18390141
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.44万
-
财政年份:2006
-
负责人:TAKIGUCHI Masafumi
-
依托单位:
Development of personal vaccine for virus
-
批准号:10557034
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$7.49万
-
财政年份:1998
-
负责人:TAKIGUCHI Masafumi
-
依托单位:
Studies of T cell Recognition for Viral Antigen Epitopes
-
批准号:10470088
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$6.91万
-
财政年份:1998
-
负责人:TAKIGUCHI Masafumi
-
依托单位:
Development of CTL induced vaccine using reverse immunogenetics.
-
批准号:06557022
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$6.85万
-
财政年份:1994
-
负责人:TAKIGUCHI Masafumi
-
依托单位:
Molecular Immunological Analyses of Recognition to T cell For Major and Minor Histocompatibility Antigens
-
批准号:02670198
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1990
-
负责人:TAKIGUCHI Masafumi
-
依托单位:
海外基金